124 related articles for article (PubMed ID: 3260319)
1. Ascorbic acid and striatal transport of [3H] 1-methyl-4-phenylpyridine (MPP+) and [3H] dopamine.
Debler EA; Hashim A; Lajtha A; Sershen H
Life Sci; 1988; 42(25):2553-9. PubMed ID: 3260319
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid.
Debler EA; Sershen H; Hashim A; Lajtha A; Reith ME
Synapse; 1991 Feb; 7(2):99-105. PubMed ID: 2011830
[TBL] [Abstract][Full Text] [Related]
3. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
Chiba K; Trevor AJ; Castagnoli N
Biochem Biophys Res Commun; 1985 May; 128(3):1228-32. PubMed ID: 3873939
[TBL] [Abstract][Full Text] [Related]
4. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
5. Effect of ascorbic acid on the synaptosomal uptake of [3H]MPP+, [3H]dopamine, and [14C]GABA.
Sershen H; Debler EA; Lajtha A
J Neurosci Res; 1987; 17(3):298-301. PubMed ID: 3496464
[TBL] [Abstract][Full Text] [Related]
6. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
[TBL] [Abstract][Full Text] [Related]
7. Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport.
Mayer RA; Kindt MV; Heikkila RE
J Neurochem; 1986 Oct; 47(4):1073-9. PubMed ID: 3489072
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+.
Shen RS; Abell CW; Gessner W; Brossi A
FEBS Lett; 1985 Sep; 189(2):225-30. PubMed ID: 3876242
[TBL] [Abstract][Full Text] [Related]
9. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
Donnan GA; Kaczmarczyk SJ; Rowe PJ; Figdor R; Mendelsohn FA
J Neurol Sci; 1986 Jun; 74(1):111-9. PubMed ID: 3487620
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparations.
Heikkila RE; Youngster SK; Manzino L; Cabbat FS; Duvoisin RC
J Neurochem; 1985 Jan; 44(1):310-3. PubMed ID: 3871120
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of [3H]MPP+ uptake in dopaminergic neurons of mouse: regional effects of MPTP neurotoxicity.
Sershen H; Mason MF; Debler EA; Lajtha A
Eur J Pharmacol; 1986 Jul; 126(3):337-9. PubMed ID: 3489627
[TBL] [Abstract][Full Text] [Related]
12. Kinetic evaluation of the commonality between the site(s) of action of cocaine and some other structurally similar and dissimilar inhibitors of the striatal transporter for dopamine.
Meiergerd SM; Schenk JO
J Neurochem; 1994 Nov; 63(5):1683-92. PubMed ID: 7931324
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
14. Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Sershen H; Reith ME; Hashim A; Lajtha A
Eur J Pharmacol; 1984 Jun; 102(1):175-8. PubMed ID: 6332738
[TBL] [Abstract][Full Text] [Related]
15. Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.
Sershen H; Reith ME; Hashim A; Lajtha A
Neuropharmacology; 1985 Dec; 24(12):1257-9. PubMed ID: 3879338
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling of dopamine uptake sites in mouse striatum: comparison of binding sites for cocaine, mazindol, and GBR 12935.
Reith ME; Selmeci G
Naunyn Schmiedebergs Arch Pharmacol; 1992 Mar; 345(3):309-18. PubMed ID: 1620235
[TBL] [Abstract][Full Text] [Related]
17. 1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes.
Willoughby J; Cowburn RF; Hardy JA; Glover V; Sandler M
J Neurochem; 1989 Feb; 52(2):627-31. PubMed ID: 2783454
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1996 Jul; 52(1):29-34. PubMed ID: 8678905
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of uptake of 1-methyl-4-phenylpyridinium ion and dopamine in striatal synaptosomes by tobacco smoke components.
Carr LA; Basham JK; York BK; Rowell PP
Eur J Pharmacol; 1992 May; 215(2-3):285-7. PubMed ID: 1396992
[TBL] [Abstract][Full Text] [Related]
20. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
Chagraoui A; Bonnet JJ; Protais P; Costentin J
Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
